AAOS 2016: IV TXA reduced blood loss in hip arthroplasty for femoral neck fracture
Tranexamic Acid Safely Reduced Blood Loss: Randomized Clinical Trial of 138 Femoral Neck Fractures
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
138 patients undergoing hip arthroplasty for acute femoral neck fracture were randomized to receive either intravenous tranexamic acid (TXA) or placebo intraoperatively. The purpose of this study was to assess the efficacy of TXA for reducing blood loss and the incidence of blood transfusion, as well as to compare the complication rates between groups at 30- and 90-day follow-up. The results displ...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE